Outlook Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2020 and Provides Corporate Update
Successfully completed NORSE 2 enrollment in July 2020NORSE 1 topline results to be reported in August 2020MONMOUTH JUNCTION, N.J., Aug. […]